2026 NPPES data Clinical Neurophysiology Physician NPI 1518462480
Verify on CMS →

Matthew Orwitz

Clinical Neurophysiology Physician in Sewell, New Jersey.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 650 in Clinical Neurophysiology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
213
Medicare Part D claims · 71 beneficiaries · Clinical Neurophysiology Physician avg: 2K
Generic prescribing
92%
generic claims · 8% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$183.84
10 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

Matthew Orwitz filed 213 Medicare Part D claims in 2024 as a Clinical Neurophysiology Physician in Sewell, New Jersey, prescribing 92% generic.

213
Part D claims, 2024
92%
generic prescribing
Likely
board-certified (heuristic)
≥48th
pct by Part D claim volume (lower-bound band)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Federal trust snapshot

What official records show about Matthew Orwitz

Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.

  • Verified

    NPI registry status

    Active listing in the CMS National Provider Identifier Registry (NPI 1518462480), first enumerated 03/24/2018.

    Source: CMS NPPES

  • Reported

    Medicare Part D participation

    Filed 213 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.

    Source: CMS Part D Prescriber PUF

  • Reported

    Board certification signal

    Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.

    Source: NUCC taxonomy + CMS participation heuristic

  • Reported

    Hospital affiliations

    1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.

    Source: CMS Care Compare

  • Reported

    Industry payment transparency

    $183.84 in reported industry payments (10 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.

    Source: CMS Open Payments

  • Not in federal data

    Individual sanction lookup

    PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.

    Source: State medical board / FSMB

This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.

CMS NPPES provider registry desk

NPI 1518462480 · Clinical Neurophysiology Physician

NPI-10 · ENUM-RECENT · TAX-NARROW · RX-LIGHT · BOOK-THIN · PHOTO-ENUM

  • NPI-10 1518462480
  • ENUM-RECENT 2018
  • TAX-NARROW 650
  • RX-LIGHT 213
  • BOOK-THIN 17 in New Jersey
  • PHOTO-ENUM Nicole Azaan, CFMP,… · 2018

Matthew Orwitz's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2024, across all CMS prescribers nationally

213 ≥ 48th percentile 48% of 1,416,883 prescribers are in lower value bands

0–200: 679,947 prescribers (48%). Below this entry. 200–400: 188,835 prescribers (13%). This entry sits in this band. 400–600: 95,866 prescribers (7%). Above this entry. 600–800: 60,107 prescribers (4%). Above this entry. 800–1,000: 43,043 prescribers (3%). Above this entry. 1,000–1,200: 33,612 prescribers (2%). Above this entry. 1,200–1,400: 27,889 prescribers (2%). Above this entry. 1,400–1,600: 23,183 prescribers (2%). Above this entry. 1,600–1,800: 19,917 prescribers (1%). Above this entry. 1,800–2,000: 17,585 prescribers (1%). Above this entry. 2K+: 226,899 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.

Source CMS Medicare Part D Prescriber Public Use File · 2024

Board certification likely (heuristic, not verified)

Matthew Orwitz practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Matthew Orwitz?

Quality data not reported

NPI registry status

Active

Issued 03/24/2018

NPI 1518462480

Primary specialty

Clinical Neurophysiology Physician

Niche

650 US NPIs in this specialty

Medicare Part D claims

213 87% vs specialty avg

2024 prescription claims

Specialty avg: 1,582

Specialty distribution in New Jersey

How Clinical Neurophysiology Physician compares to other specialties among New Jersey providers

New Jersey providers
Mental Health Counselor6.2%Physical Therapist5.8%Student in an Organized Heal…5.6%Clinical Social Worker5.5%Pharmacist5%Internal Medicine Physician3.1%Clinical Neurophysiology Phy…0%
Largest specialties in New Jersey (% of in-state providers)

Board certification

Not published by CMS

CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Clinical Neurophysiology Physician. Verify directly:

How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Practice Address

VIRTUA HEALTH & WELLNESS CENTER - WASHINGTON TOWNSHIP
Sewell, NJ 08080

Provider Details

NPI 1518462480
Specialty Clinical Neurophysiology Physician
Gender Male
NPI Issued 03/24/2018

Hospital and facility affiliations

Facilities where Matthew Orwitz bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

Virtua Medical Group, PA
Voorhees, NJ

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) - CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Matthew Orwitz. Source: openpaymentsdata.cms.gov.

Total received

$184

Largest payer

UCB, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Generic-heavy

Matthew Orwitz - brand share 8.0%
Clinical Neurophysiology Physician average

8% brand-name claims vs 92% generic, on 213 2024 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2024.

213
Total Claims
$24K
Total Drug Cost
71
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
376.033
Total Day Supply
11,019
Brand vs Generic
8% brand / 92% generic
Brand Drug Cost
$15K
Generic Drug Cost
$9K

Patient Demographics

Average Patient Age
71.6 years
Avg HCC Risk Score
1.77
Gender Split
45% female / 55% male
Age Distribution
<65: 15, 65-74: N/A, 75-84: 32, 85+: N/A

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.

What Matthew Orwitz prescribes most

Top Medicare Part D drugs by claim count, 2024

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2024
Drug Claims
Levetiracetam
33
Carbidopa-Levodopa
Carbidopa/Levodopa
26
Lamotrigine
19
Lacosamide
18
Gabapentin
15
Baclofen
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Clinical Neurophysiology Physician Overview

How Matthew Orwitz fits within the Clinical Neurophysiology Physician landscape nationally.

650
Clinical Neurophysiology Physician Providers in US
50
States with Clinical Neurophysiology Physician
1,582
Avg Claims per Provider

Matthew Orwitz's 213 claims are below the specialty average of 1,582.

Nationwide Clinical Neurophysiology Physician peers with similar MIPS or enrollment year

Two federal-record peer sets for Orwitz, both outside New Jersey so the neighborhoods are not geographic containment.

Same NPPES enumeration year (2018)

Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.

Nearby Clinical Neurophysiology Physician Providers in New Jersey

Other clinicians with the same primary specialty enrolled in New Jersey, drawn from the same CMS NPPES roster as Orwitz.

One of 17 Clinical Neurophysiology Physician providers enrolled in New Jersey, 5 are shown here.

Compare Clinical Neurophysiology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is Matthew Orwitz's specialty?
Matthew Orwitz specializes in Clinical Neurophysiology Physician and practices in Sewell, New Jersey.
How much does Matthew Orwitz prescribe under Medicare Part D?
In 2024, Matthew Orwitz wrote 213 Medicare Part D claims totaling $24K in drug costs for 71 beneficiaries.
Where is Matthew Orwitz located?
Matthew Orwitz is located at VIRTUA HEALTH & WELLNESS CENTER - WASHINGTON TOWNSHIP, Sewell, NJ, 08080. Phone: (856) 988-3444.
What is Matthew Orwitz's NPI number?
Matthew Orwitz's National Provider Identifier (NPI) is 1518462480, issued on 03/24/2018.
Does Matthew Orwitz prescribe more brand-name or generic drugs?
Matthew Orwitz's prescribing is 8% brand-name and 92% generic drugs by claim count, with $15K in brand drug costs.
How many Clinical Neurophysiology Physician providers are there in the US?
There are 650 Clinical Neurophysiology Physician providers across 50 states in the US. The average Clinical Neurophysiology Physician provider writes 1,582 Medicare Part D claims per year.
What drugs does Matthew Orwitz prescribe most often?
Based on 2024 Medicare Part D data, Matthew Orwitz's most frequently prescribed drugs include Levetiracetam, Carbidopa-Levodopa, Lamotrigine. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Matthew Orwitz accept Medicare?
Matthew Orwitz appears in CMS Medicare data with 213 Part D claims and 71 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Matthew Orwitz's credentials?
Matthew Orwitz's NPI is 1518462480. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.